Our findings show that TLR3 is a novel contributor to cocaine-induced reward behaviors and TLR3/dsRNA complex inhibitor might serve as potential therapeutic targets for the treatment of cocaine addiction. The gene discussed is TLR3; the disease is cocaine dependence.